1. Home
  2. NSPR vs NRT Comparison

NSPR vs NRT Comparison

Compare NSPR & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.72

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

NRT

North European Oil Royality Trust

HOLD

Current Price

$7.00

Market Cap

76.7M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
NRT
Founded
2005
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
76.7M
IPO Year
2009
1995

Fundamental Metrics

Financial Performance
Metric
NSPR
NRT
Price
$0.72
$7.00
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
157.0K
61.4K
Earning Date
05-04-2026
05-29-2026
Dividend Yield
N/A
10.18%
EPS Growth
N/A
N/A
EPS
N/A
0.43
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
$16.56
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$4.76
52 Week High
$2.93
$10.49

Technical Indicators

Market Signals
Indicator
NSPR
NRT
Relative Strength Index (RSI) 28.77 32.95
Support Level N/A $6.25
Resistance Level $1.04 $8.68
Average True Range (ATR) 0.09 0.38
MACD -0.00 -0.07
Stochastic Oscillator 5.72 9.62

Price Performance

Historical Comparison
NSPR
NRT

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

Share on Social Networks: